Abstract Forty-four classical PKU patients have been screened for various mutations. The newly identified IVS 10 splicing mutation was found in 32% of the mutant alleles and comprises 74-5% of the mutations that could be typed: 261arg-gln (6-8%), 158arg-gly (2.3%) 252arg-trp (1P1%), 2809gu-lYs (-), and 272g1y-s'oP (-) were the other mutations that were screened.
Phenylketonuria (PKU), which results from a deficiency of hepatic enzyme phenylalanine hydroxylase (PAH), is a common inborn error of metabolism. The average incidence of PKU is 1/10 000 in Caucasians.I2 The frequency of PKU in Turkey, based on the results of a newborn screening programme in effect since 1983, is 1/4370.3 A high rate of consanguineous marriages (21-06%) in Turkey may be a contributing factor to this high incidence. 4 Molecular genetic studies of the PAH gene began as a result of the cloning of the cDNA. 5 The majority of PKU chromosomes are associated with haplotypes 1-4 as determined by restriction fragment length polymorphisms (RFLPs) created by seven restriction endo- Results and discussion Table 2 shows the distribution of various mutations in the 88 PKU mutant alleles. Fortytwo percent of the alleles could be identified for a particular mutation and the IVS 10 splicing mutation by itself comprised 75 7% of the mutations identified.
Of 44 patients 11 were homozygous for the IVS 10 splicing mutation, two were homozygous for the codon 261 mutation, and seven Table 2 Distribution of mutations in the mutant PKU alleles (n = 88). IVS 10 splice mutation comprises 75 5% of the mutations that could be determined. 
